TG Therapeutics shareholders reject say-on-pay and share increase at annual meeting

TG THERAPEUTICS, INC.

Advisory say-on-pay failed: 26.0M For (37.4%) vs 43.5M Against (62.6%).
Proposal to increase authorized shares from 175M to 200M failed; 69.9M For but not majority of outstanding 149.4M shares.
Only directors Michael Weiss (75.8%) and Laurence Charney (66.1%) received majority for; others <60%.
Ratification of KPMG as auditor approved with 102.3M For (99.8% of votes cast).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.